Fonseca D
Research has shown its ability to reduce inflammatory cytokines which cause oxidative stress and inflammatory diseases such as Alzheimers, Parkinsons, heart disease, diabetes, kidney disease, and more Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) is a naturally occurring tetrapeptide from thymosin beta-4 that exhibits anti-inflammatory, pro-angiogenic, and anti-scarring properties
Injectable BPC-157: Higher Absorption and Targeted Repair Typical range: 2001,000 mcg per day Common dose: 500 mcg per day Method: Subcutaneous (SubQ) injection near the injury site or abdomen Cycle: 26 weeks depending on injury severity Injectable BPC-157 offers the highest bioavailability and fastest results, especially for tendon, ligament, and muscle injuries
2020 Aug 4;32(2):154-175
Avoid sustained temperatures above 25C
BPC-157 All variants sold out Bulk Savings Save more when you buy more the discount applies automatically